Materials & Resources » Chemicals | Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler Strahlen- und Medizintechnik AG | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
10,447.00
6,497.00
10,366.00
9,786.00
15,122.00
16,889
Depreciation, Depletion & Amortization
7,530.00
7,143.00
8,417.00
8,290.00
8,645.00
8,444
Other Funds
1,230.00
543.00
682.00
420.00
155.00
431
Funds from Operations
17,560.00
14,164.00
12,690.00
22,343.00
20,916.00
24,902
Changes in Working Capital
2,911.00
4,284.00
2,582.00
2,923.00
5,473.00
3,845
Net Operating Cash Flow
14,649.00
9,880.00
15,272.00
19,420.00
26,389.00
21,057
Capital Expenditures
9,650.00
7,815.00
3,843.00
5,332.00
4,160.00
Sale of Fixed Assets & Businesses
17.00
38.00
23.00
333.00
13,129.00
Purchase/Sale of Investments
-
22.00
5,366.00
303.00
1,598.00
Net Investing Cash Flow
17,367.00
10,813.00
972.00
5,527.00
5,113.00
Cash Dividends Paid - Total
3,173.00
3,173.00
3,173.00
3,173.00
3,490.00
Issuance/Reduction of Debt, Net
6,080.00
4,058.00
3,257.00
3,885.00
5,297.00
Net Financing Cash Flow
1,677.00
7,774.00
7,462.00
9,111.00
9,517.00
Net Change in Cash
1,428.00
7,590.00
9,642.00
5,101.00
21,140.00
Free Cash Flow
4,999.00
2,065.00
11,429.00
14,088.00
22,229.00
Net Assets from Acquisitions
7,356.00
780.00
574.00
225.00
5,454.00
Change in Capital Stock
-
-
350.00
1,633.00
575.00
Exchange Rate Effect
387.00
1,117.00
860.00
319.00
845.00
Other Uses
378.00
2,278.00
-
-
-

About Eckert & Ziegler Strahlen- und Medizintechnik

View Profile
Address
Robert-Rössle-Strasse 10
Berlin Berlin 13125
Germany
Employees -
Website http://www.ezag.de
Updated 07/08/2019
Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific, and industrial use. It operates through the following segments: Radiation Therapy, Isotope Products, Radiopharma, and Holding. The Radiation Therapy segment concentrates on product development, manufacturing, the market introduction, and the sale of radioactive products for cancer therapy.